Graphene oxide-chloroquine nanoconjugate induce necroptotic death in A549 cancer cells through autophagy modulation

Nanomedicine (Lond). 2018 Sep;13(18):2261-2282. doi: 10.2217/nnm-2018-0086. Epub 2018 Oct 4.

Abstract

Aim: Chloroquine (Chl) has shown its potential in cancer therapy and graphene oxide (GO) exhibited excellent tumor-targeting ability, biocompatibility and low toxicity. We have endeavored to conjugate Chl to GO sheets and investigated the nonproliferation action on A549 cell lines along with cell signaling pathways.

Materials & methods: Cellular toxicity, autophagic flux modulation and cell death mechanism induced by GO-Chl have been investigated on A549 cell lines.

Results & conclusion: GO-Chl induces accumulation of autophagosomes (monodansylcadaverine staining, green fluorescence protein-tagged LC3 plasmid and transmission electron microscopy observations) in A549 cells through the blockade of autophagic flux that serves as scaffold for necrosome assembling and activates necroptotic cell death. GO-Chl nanoconjugate could be used as an effective cancer therapeutic agent, by targeting the autophagy necroptosis axis.

Keywords: A549; autophagosomes; autophagy; cancer therapy; chloroquine; endocytosis; graphene oxide; lysosome; nanoconjugate; necroptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Autophagy / drug effects*
  • Cell Proliferation / drug effects
  • Chloroquine / chemistry*
  • Chloroquine / pharmacology*
  • Endocytosis / drug effects
  • Flow Cytometry
  • Graphite / chemistry*
  • Graphite / pharmacology*
  • Humans
  • Lysosomes / drug effects
  • Nanoconjugates / chemistry*
  • Oxidative Stress / drug effects
  • Reactive Oxygen Species / metabolism

Substances

  • Nanoconjugates
  • Reactive Oxygen Species
  • graphene oxide
  • Graphite
  • Chloroquine